Paul E. Freiman, Director at NovaBay Pharmaceuticals, Inc. (NBY), sold 25,000 shares at $2.33 ($58K) on 2009-06-11, disclosed to the SEC on 2009-06-15.
Open-market sale of $58k NBY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |